8HBL image
Deposition Date 2022-10-29
Release Date 2023-07-12
Last Version Date 2024-10-30
Entry Detail
PDB ID:
8HBL
Keywords:
Title:
Crystal structure of the SARS-unique domain (SUD) of SARS-CoV-2 (1.58 angstrom resolution)
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.58 Å
R-Value Free:
0.17
R-Value Work:
0.13
R-Value Observed:
0.14
Space Group:
P 31 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Non-structural protein 3
Mutagens:L516C, Y647C
Chain IDs:A
Chain Length:260
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target.
Nat Commun 14 3999 3999 (2023)
PMID: 37414753 DOI: 10.1038/s41467-023-39709-6

Abstact

SARS-CoV-2 nsp3 is essential for viral replication and host responses. The SARS-unique domain (SUD) of nsp3 exerts its function through binding to viral and host proteins and RNAs. Herein, we show that SARS-CoV-2 SUD is highly flexible in solution. The intramolecular disulfide bond of SARS-CoV SUD is absent in SARS-CoV-2 SUD. Incorporating this bond in SARS-CoV-2 SUD allowed crystal structure determination to 1.35 Å resolution. However, introducing this bond in SARS-CoV-2 genome was lethal for the virus. Using biolayer interferometry, we screened compounds directly binding to SARS-CoV-2 SUD and identified theaflavin 3,3'-digallate (TF3) as a potent binder, Kd 2.8 µM. TF3 disrupted the SUD-guanine quadruplex interactions and exhibited anti-SARS-CoV-2 activity in Vero E6-TMPRSS2 cells with an EC50 of 5.9 µM and CC50 of 98.5 µM. In this work, we provide evidence that SARS-CoV-2 SUD harbors druggable sites for antiviral development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures